# Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators

> **NCT02197845** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 353 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **BEHAVIORAL:** Patient Navigator
- **BEHAVIORAL:** Recruitment into Specialty Care

## Key facts

- **NCT ID:** NCT02197845
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-07-07
- **Final completion:** 2018-12-31
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2023-06-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197845, "Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02197845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*